Gene Delivery
Partnership
Approach
About
News
Blog
Menu
Close
Generative AAV capsid diversification by latent interpolation
Publications
April 17, 2021
Biorxiv
TOC LINK
TOC LINK
Publications
Published
April 17, 2021
More like this
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
April 27, 2026
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
April 27, 2026
Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 13, 2026
Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Announcements
Dyno Therapeutics
May 13, 2026
Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)
Announcements
Dyno Therapeutics
May 13, 2026
Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)
Announcements
Dyno Therapeutics
May 13, 2026
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
Announcements
Dyno Therapeutics
April 8, 2026
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
Announcements
Dyno Therapeutics
April 8, 2026
343 Arsenal St
Watertown, MA 02472
© Dyno 2025
Privacy Policy
Terms + Conditions